Comparison between Tc-99m WBC SPECT/CT and MRI for the diagnosis of biopsy-proven diabetic foot osteomyelitis

Javier La Fontaine, Kavita Bhavan, Kenrick Lam, Suzanne Van Asten, William Erdman, Lawrence A. Lavery, Orhan K. Öz

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective. Magnetic resonance imaging (MRI) is the recommended diagnostic imaging technique for diabetic foot osteomyelitis (DFO), with a reported accuracy of 79%. The gold standard to diagnose osteomyelitis is bone biopsy, with a positive culture and/or histopathology findings consistent with osteomyelitis. The purposes of this study are to assess the accuracy of technetium-99m (Tc-99m) labeled white blood cell (WBC) single-photon emission computed tomography/computed tomography (SPECT/CT) hybrid imaging for diagnosing DFO confirmed by bone biopsy and to compare that to the diagnostic accuracy of an MRI. Materials and Methods. The authors performed a retrospective chart review of 166 patients who received a bone biopsy to confirm the diagnosis of a suspected DFO at a large municipal hospital between 2010 and 2013. Patients were selected on the basis of whether they received an MRI or a SPECT/CT. Patients whose scans were not within a clinically relevant time frame of the biopsy were excluded. Imaging results were correlated with probability of osteomyelitis determined by bone biopsy. Results. For inclusion criteria, 110 patients met the study's criteria: 52 SPECT/CT patients and 58 MRI patients. The sensitivity, specificity, positive predictive value, and negative predictive value of SPECT/CT were 89%, 35%, 74%, and 60%, respectively; the corresponding values for MRI were 87%, 37%, 74%, and 58%, respectively. There were no significant differences in accuracy of diagnosing DFO between imaging techniques. Conclusion. This data suggests that the diagnostic accuracy of SPECT/CT imaging in DFOs is similar to an MRI.

Original languageEnglish (US)
Pages (from-to)271-278
Number of pages8
JournalWounds
Volume28
Issue number8
StatePublished - Aug 1 2016

Fingerprint

Diabetic Foot
Technetium
Osteomyelitis
Leukocytes
Magnetic Resonance Imaging
Biopsy
Bone and Bones
Multimodal Imaging
Municipal Hospitals
Diagnostic Imaging
Single Photon Emission Computed Tomography Computed Tomography
Sensitivity and Specificity

Keywords

  • diabetes
  • diabetic foot osteomyelitis
  • imaging
  • infection
  • osteomyelitis

ASJC Scopus subject areas

  • Surgery
  • Medical–Surgical

Cite this

Comparison between Tc-99m WBC SPECT/CT and MRI for the diagnosis of biopsy-proven diabetic foot osteomyelitis. / La Fontaine, Javier; Bhavan, Kavita; Lam, Kenrick; Van Asten, Suzanne; Erdman, William; Lavery, Lawrence A.; Öz, Orhan K.

In: Wounds, Vol. 28, No. 8, 01.08.2016, p. 271-278.

Research output: Contribution to journalArticle

@article{a8cbf722f0a348d28e7b27cc01e44927,
title = "Comparison between Tc-99m WBC SPECT/CT and MRI for the diagnosis of biopsy-proven diabetic foot osteomyelitis",
abstract = "Objective. Magnetic resonance imaging (MRI) is the recommended diagnostic imaging technique for diabetic foot osteomyelitis (DFO), with a reported accuracy of 79{\%}. The gold standard to diagnose osteomyelitis is bone biopsy, with a positive culture and/or histopathology findings consistent with osteomyelitis. The purposes of this study are to assess the accuracy of technetium-99m (Tc-99m) labeled white blood cell (WBC) single-photon emission computed tomography/computed tomography (SPECT/CT) hybrid imaging for diagnosing DFO confirmed by bone biopsy and to compare that to the diagnostic accuracy of an MRI. Materials and Methods. The authors performed a retrospective chart review of 166 patients who received a bone biopsy to confirm the diagnosis of a suspected DFO at a large municipal hospital between 2010 and 2013. Patients were selected on the basis of whether they received an MRI or a SPECT/CT. Patients whose scans were not within a clinically relevant time frame of the biopsy were excluded. Imaging results were correlated with probability of osteomyelitis determined by bone biopsy. Results. For inclusion criteria, 110 patients met the study's criteria: 52 SPECT/CT patients and 58 MRI patients. The sensitivity, specificity, positive predictive value, and negative predictive value of SPECT/CT were 89{\%}, 35{\%}, 74{\%}, and 60{\%}, respectively; the corresponding values for MRI were 87{\%}, 37{\%}, 74{\%}, and 58{\%}, respectively. There were no significant differences in accuracy of diagnosing DFO between imaging techniques. Conclusion. This data suggests that the diagnostic accuracy of SPECT/CT imaging in DFOs is similar to an MRI.",
keywords = "diabetes, diabetic foot osteomyelitis, imaging, infection, osteomyelitis",
author = "{La Fontaine}, Javier and Kavita Bhavan and Kenrick Lam and {Van Asten}, Suzanne and William Erdman and Lavery, {Lawrence A.} and {\"O}z, {Orhan K.}",
year = "2016",
month = "8",
day = "1",
language = "English (US)",
volume = "28",
pages = "271--278",
journal = "Wounds",
issn = "1044-7946",
publisher = "HMP Communications",
number = "8",

}

TY - JOUR

T1 - Comparison between Tc-99m WBC SPECT/CT and MRI for the diagnosis of biopsy-proven diabetic foot osteomyelitis

AU - La Fontaine, Javier

AU - Bhavan, Kavita

AU - Lam, Kenrick

AU - Van Asten, Suzanne

AU - Erdman, William

AU - Lavery, Lawrence A.

AU - Öz, Orhan K.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Objective. Magnetic resonance imaging (MRI) is the recommended diagnostic imaging technique for diabetic foot osteomyelitis (DFO), with a reported accuracy of 79%. The gold standard to diagnose osteomyelitis is bone biopsy, with a positive culture and/or histopathology findings consistent with osteomyelitis. The purposes of this study are to assess the accuracy of technetium-99m (Tc-99m) labeled white blood cell (WBC) single-photon emission computed tomography/computed tomography (SPECT/CT) hybrid imaging for diagnosing DFO confirmed by bone biopsy and to compare that to the diagnostic accuracy of an MRI. Materials and Methods. The authors performed a retrospective chart review of 166 patients who received a bone biopsy to confirm the diagnosis of a suspected DFO at a large municipal hospital between 2010 and 2013. Patients were selected on the basis of whether they received an MRI or a SPECT/CT. Patients whose scans were not within a clinically relevant time frame of the biopsy were excluded. Imaging results were correlated with probability of osteomyelitis determined by bone biopsy. Results. For inclusion criteria, 110 patients met the study's criteria: 52 SPECT/CT patients and 58 MRI patients. The sensitivity, specificity, positive predictive value, and negative predictive value of SPECT/CT were 89%, 35%, 74%, and 60%, respectively; the corresponding values for MRI were 87%, 37%, 74%, and 58%, respectively. There were no significant differences in accuracy of diagnosing DFO between imaging techniques. Conclusion. This data suggests that the diagnostic accuracy of SPECT/CT imaging in DFOs is similar to an MRI.

AB - Objective. Magnetic resonance imaging (MRI) is the recommended diagnostic imaging technique for diabetic foot osteomyelitis (DFO), with a reported accuracy of 79%. The gold standard to diagnose osteomyelitis is bone biopsy, with a positive culture and/or histopathology findings consistent with osteomyelitis. The purposes of this study are to assess the accuracy of technetium-99m (Tc-99m) labeled white blood cell (WBC) single-photon emission computed tomography/computed tomography (SPECT/CT) hybrid imaging for diagnosing DFO confirmed by bone biopsy and to compare that to the diagnostic accuracy of an MRI. Materials and Methods. The authors performed a retrospective chart review of 166 patients who received a bone biopsy to confirm the diagnosis of a suspected DFO at a large municipal hospital between 2010 and 2013. Patients were selected on the basis of whether they received an MRI or a SPECT/CT. Patients whose scans were not within a clinically relevant time frame of the biopsy were excluded. Imaging results were correlated with probability of osteomyelitis determined by bone biopsy. Results. For inclusion criteria, 110 patients met the study's criteria: 52 SPECT/CT patients and 58 MRI patients. The sensitivity, specificity, positive predictive value, and negative predictive value of SPECT/CT were 89%, 35%, 74%, and 60%, respectively; the corresponding values for MRI were 87%, 37%, 74%, and 58%, respectively. There were no significant differences in accuracy of diagnosing DFO between imaging techniques. Conclusion. This data suggests that the diagnostic accuracy of SPECT/CT imaging in DFOs is similar to an MRI.

KW - diabetes

KW - diabetic foot osteomyelitis

KW - imaging

KW - infection

KW - osteomyelitis

UR - http://www.scopus.com/inward/record.url?scp=84984678105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984678105&partnerID=8YFLogxK

M3 - Article

C2 - 27560470

AN - SCOPUS:84984678105

VL - 28

SP - 271

EP - 278

JO - Wounds

JF - Wounds

SN - 1044-7946

IS - 8

ER -